PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.

The Journal of the Turkish-German Gynecological Association, published by GALENOS PUBL HOUSE, stands as a significant contribution to the field of obstetrics and gynecology, fostering a vital dialogue between Turkish and German medical communities since its establishment. This peer-reviewed, Open Access journal, which has been accessible since 2000, provides a platform for the dissemination of cutting-edge research, clinical practices, and reviews that are pivotal for advancing women's health. With a current impact factor correlation reflecting its status within the Q3 category in the obstetrics and gynecology domain, the journal is ranked #108 out of 209 in Scopus, placing it in the 48th percentile for its field. Covering a broad range of topics from innovative treatment methods to emerging technologies in gynecology, this journal is dedicated to enriching the academic landscape and providing healthcare professionals, researchers, and students with valuable insights and knowledge essential for improving patient outcomes. The journal’s headquarters in Turkey underscores its commitment to enriching local and international discourse in women's health.

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a premier journal dedicated to advancing the fields of hematology and oncology. With its ISSN 0889-8588 and E-ISSN 1558-1977, this esteemed publication has been a cornerstone of clinical scholarship since its inception in 1987, providing comprehensive annual updates that bridge the gap between research and clinical practice. Known for its rigorous editorial standards and impactful contributions, the journal holds a respectable Q2 quartile classification in both hematology and oncology as of 2023, ranking it in the 50th percentile among its peers. Although it is not an open-access journal, the content is accessible to institutions and professionals worldwide. As the scope of the journal expands through 2024, it continues to attract an audience of researchers, healthcare professionals, and students who seek to stay informed on the latest advancements, treatment modalities, and groundbreaking studies in the fields of hematology and oncology.

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

ONCOLOGIST is a premier, open-access journal published by Oxford University Press, advancing the field of cancer research since its inception in 1996. With an impressive H-Index and a prestigious placement within the Q1 category in Cancer Research, Medicine, and Oncology for 2023, ONCOLOGIST stands at the forefront of oncological science, boasting a Scopus rank of #55 out of 404 in Medicine and #47 out of 230 in Cancer Research. This journal not only disseminates cutting-edge research but also aims to foster multidisciplinary approaches that are critical for addressing the complex challenges faced in cancer therapy and survivorship. Be part of a vibrant community as you explore impactful research articles that contribute to the global conversation on cancer. ONCOLOGIST is dedicated to providing an accessible platform for authors and readers alike, ensuring that high-quality research is available to all stakeholders in the fight against cancer.

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

Gynecologic Oncology Reports is a pivotal interdisciplinary journal published by Elsevier Science Inc. that has been dedicated to advancing the understanding of women's health since its inception in 2014. This Open Access journal, available to a global audience, facilitates the dissemination of high-quality research in the fields of gynecology and oncology, allowing for the free exchange of knowledge and fostering collaboration among researchers, clinicians, and students. With an impact factor reflective of its commitment to clinical relevance, Gynecologic Oncology Reports holds a Q3 ranking in both obstetrics and gynecology as well as oncology categories, contributing to its visibility and the prestige of published work. Situated in the Netherlands and operating within an open-access framework, it ensures that critical findings and advancements reach a broad readership. The journal serves as a vital resource for those aiming to stay at the forefront of gynecologic oncology, promoting improved patient outcomes through cutting-edge research. As it converges towards its 10th anniversary in 2024, Gynecologic Oncology Reports continues to be an essential platform for scholarly communication in this important field.